Trowbridge, United Kingdom

Claire Ferrao

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Claire Ferrao

Introduction

Claire Ferrao is an accomplished inventor based in Trowbridge, GB. She has made significant contributions to the field of detection methods, particularly in identifying specific genetic sequences. With a total of three patents to her name, her work has implications for public health and diagnostics.

Latest Patents

One of Claire's latest patents is a detection method that focuses on identifying the presence of specific target sequences in a sample. This method involves detecting a first target sequence taken from the NGO1642 gene and/or a second target sequence taken from the NGO1012 gene. The process may include amplifying the target sequence and hybridizing it to a nucleic acid probe for identification. Additionally, this method allows for the simultaneous detection of other target sequences from various pathogens. Another notable patent is specifically aimed at detecting Neisseria gonorrhoeae, utilizing a similar approach to identify genetic markers associated with this pathogen.

Career Highlights

Throughout her career, Claire has worked with notable companies such as Binx Health Limited and Atlas Genetics Limited. Her experience in these organizations has allowed her to refine her skills and contribute to innovative solutions in the field of genetic detection.

Collaborations

Claire has collaborated with professionals like Danny Filer and Sharon Chadwick, enhancing her work through shared expertise and insights.

Conclusion

Claire Ferrao's innovative approaches to detection methods highlight her significant role in advancing genetic diagnostics. Her contributions are vital for improving public health outcomes and demonstrate the importance of innovation in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…